Johnson & Johnson

Four of the biggest American health companies have tentatively agreed to pay $26 billion to settle their opioid liability. Tax breaks could allow them to claw back $4 billion.

McKinsey is the latest major American corporation to face legal, financial and public relations peril stemming from its role in the nation's deadly opioid epidemic.

The move by Eli Lilly came less than 24 hours after Johnson & Johnson paused further dosing in all of its COVID-19 vaccine candidate clinical trials while it investigated a volunteer's illness.

Thousands of lawsuits that ground to a halt because of COVID-19 are moving forward again as local, state and federal courts reopen around the U.S.

The new number from Judge Thad Balkman comes nearly three months after he ordered the drugmaker to pay $572 million for its role in the opioid crisis. Both sides had questioned that sum.

Purdue Pharma, Johnson & Johnson and other health care giants are discussing potential deals with authorities that could resolve thousands of lawsuits they're facing over the U.S. opioid epidemic.

In a landmark ruling, Judge Thad Balkman ruled in favor of Oklahoma in its lawsuit to hold the drugmaker accountable for the costs of opioid addiction in the state.

The City of Columbus has filed a lawsuit against three drug manufacturers, five distributors and three individuals the city council president calls…

Republican Ohio Attorney General Mike DeWine has filed a lawsuit against five major drug companies, saying they have contributed to the opioid epidemic.…

As Ohio's heroin overdose epidemic nears a record high in deaths, lobbyists representing prescription drug makers poured more than 3.5 million into Ohio…